# TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer

> **NCT05625932** · PHASE3 · COMPLETED · sponsor: **Galician Research Group on Digestive Tumors** · enrollment: 232 (actual)

## Conditions studied

- Colorectal Cancer Metastatic
- Thromboembolism

## Interventions

- **DRUG:** Tinzaparin

## Key facts

- **NCT ID:** NCT05625932
- **Lead sponsor:** Galician Research Group on Digestive Tumors
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-02
- **Primary completion:** 2025-06-04
- **Final completion:** 2025-06-04
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05625932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05625932, "TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05625932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*